When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Quest Diagnostics Threatens Myriad's Grip on BRCA Tests - AOL

   www.aol.com/2013/10/17/quest-diagnostics...

   Quest Diagnostics is challenging Myriad Genetics stranglehold on the BRCA1 and BRCA2 cancer testing market. Quest announced that it's rolling out a cheaper alternative in hopes of winning share in ...

3. Breast Cancer Gene: Why Most Women Can't Do What Angelina ...

   www.aol.com/news/2013-05-15-angelina-jolie...

   The first issue is the test. The BRCA1 and BRCA2 tests, which may have saved Jolie's life, cost $3,000 to administer. Donna Faranda, helpline coordinator for Share Cancer Support, notes that there ...

4. Guidelines say more women may need breast cancer gene test - AOL

   www.aol.com/news/2019-08-26-guidelines-say-more...

   Cancer groups have similar recommendations for BRCA testing, and increasingly urge that the newly diagnosed be tested, too, because the inherited risk can impact choices about surgery and other ...

5. BRCA mutation - Wikipedia

   en.wikipedia.org/wiki/BRCA_mutation

   The quickest, simplest, and lowest cost test uses positive test results from a blood relative and checks only for the single mutation that is known to be present in the family. If no relative has previously disclosed positive test results, then a full test that checks the entire sequence of both BRCA1 and BRCA2 can be performed.

6. Breast cancer screening - Wikipedia

   en.wikipedia.org/wiki/Breast_cancer_screening

   Mammography is a common screening method, since it is relatively fast and widely available in developed countries. Mammography is a type of radiography used on the breasts. . It is typically used for two purposes: to aid in the diagnosis of a woman who is experiencing symptoms or has been called back for follow-up views (called diagnostic mammography), and for medical screening of apparently ...

7. Cancer biomarker - Wikipedia

   en.wikipedia.org/wiki/Cancer_biomarker

   While numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers have already been used at some point in patient care; including, AFP (liver cancer), BCR-ABL (chronic myeloid leukemia), BRCA1 / BRCA2 (breast/ovarian cancer), BRAF V600E (melanoma/colorectal cancer), CA-125 ...